Why Hims & Hers Health (HIMS) Is Down 6.8% After Amazon Pharmacy Adds Wegovy Weight-Loss Pill [Yahoo! Finance]
Hims & Hers Health, Inc. Class A (HIMS)
Company Research
Source: Yahoo! Finance
This move directly targets the fast-growing weight management segment where Hims & Hers Health participates, raising fresh questions about how differentiated and resilient its broader telehealth platform and recurring-care model really are beyond GLP-1 offerings. We'll now examine how Amazon Pharmacy's move into Wegovy pills could influence Hims & Hers Health's investment narrative and long-term platform thesis. Trump has pledged to "unleash" American oil and gas and these 22 US stocks have developments that are poised to benefit To own Hims & Hers Health, you need to believe in its broader telehealth platform, recurring-care model and diversification beyond GLP-1 weight loss. Amazon Pharmacy's Wegovy pill launch sharpens competitive pressure in weight management but does not obviously alter Hims' near term catalyst, which still hinges on sustaining high retention across multi-condition subscriptions. The most immediate risk remains concentration in a few high-growth categories
Show less
Read more
Impact Snapshot
Event Time:
HIMS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
HIMS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
HIMS alerts
High impacting Hims & Hers Health, Inc. Class A news events
Weekly update
A roundup of the hottest topics
HIMS
News
- Hims & Hers And HIMZ: Short-Term Pain From Novo, Long-Term Opportunity Still Bright [Seeking Alpha]Seeking Alpha
- BofA Maintains an Underperform Rating on Hims & Hers Health, Inc. (HIMS) [Yahoo! Finance]Yahoo! Finance
- Hims & Hers: Growth Catalysts Or Margin Trap [Seeking Alpha]Seeking Alpha
- Hims & Hers Health (NYSE:HIMS) is now covered by analysts at Evercore ISI. They set an "in-line" rating and a $33.00 price target on the stock.MarketBeat
- Is It Too Late To Consider Hims & Hers Health (HIMS) After Recent Share Price Pullback [Yahoo! Finance]Yahoo! Finance
HIMS
Earnings
- 11/3/25 - Miss
HIMS
Sec Filings
- 1/7/26 - Form 4
- 12/23/25 - Form 4
- 12/22/25 - Form 144
- HIMS's page on the SEC website